Medistep Healthcare Limited IPO Details
SME
Medistep Healthcare IPO opens for subscription on 08 Aug 2025 and closes on 12 Aug 2025. The IPO will be listed on NSE with the tentative listing date set for 18 Aug 2025.
Medistep Healthcare IPO price band has been fixed at ₹43 – ₹43 per share.The face value is ₹10 per share with a lot size of 3000.
Medistep Healthcare IPO total issue size comprises 37,44,000 shares (aggregating up to ₹16.10 Cr). This includes a fresh issue of 37,44,000 shares (aggregating up to ₹16.10 Cr). Pre-issue shareholding stands at 1,04,65,546, which will increase to 1,42,09,546 post-issue.
Medistep Healthcare IPO carries a ₹8 (18.6%) GMP, reflecting investor sentiment.
Medistep Healthcare IPO Lot Size : Individual Minimum is 2 lots (6,000 shares) amounting to ₹258,000. Individual Maximum is 2 lots (6,000 shares) amounting to ₹258,000. HNI Minimum is 3 lots (9,000 shares) amounting to ₹387,000.
The Lead Managers for Medistep Healthcare IPO are crucial for the offering's success. They are responsible for a wide range of tasks, including preparing the company for the public market, managing the regulatory filings, and marketing the IPO to potential investors. The lead manager for this offering is Fast Track Finsec Pvt Ltd. To assess their past performance and success in previous IPOs, you can view the Lead Manager Performance Summary report.
For SME (Small and Medium-sized Enterprise) IPOs, a Market Maker is appointed to ensure liquidity and stability for the stock once it is listed. They do this by continuously quoting bid and ask prices, ensuring there is a market for the shares. The appointed market maker for this IPO is Nirman Share Brokers Private Limited. You can analyze their track record by checking the Market Maker Performance Summary report.
For detailed information, Refer to the Medistep Healthcare Limited RHP.
Medistep Healthcare IPO Details
Medistep Healthcare IPO Subscription
Medistep Healthcare IPO Application Wise Breakup
Medistep Healthcare IPO Dates
- 08 Aug 2025Opening dateOPD
- 12 Aug 2025Closing dateCOD
- 13 Aug 2025Allotment Date BOA
- 14 Aug 2025Initiation of RefundsIOR
- 14 Aug 2025Credit of SharesCOS
- 18 Aug 2025Listing dateLID
Medistep Healthcare IPO Lot Size
Application | Lots | Shares | Amount |
---|---|---|---|
Individual Minimum | 2 | 6000 | ₹258,000 |
Individual Maximum | 2 | 6000 | ₹258,000 |
HNI Minimum | 3 | 9000 | ₹387,000 |
Medistep Healthcare IPO Reservation
Promoter Holding
Medistep Healthcare IPO Valuations
Medistep Healthcare Financial Information
Period Ended | 30 Jun 2024 | 31 Mar 2024 | 31 Mar 2023 | 31 Mar 2022 |
Assets | 24.02 | 14.96 | 14.66 | 7.1 |
Total Income | 11.25 | 31.63 | 27.74 | 7.62 |
Profit After Tax | 1.02 | 2.91 | 0.92 | 0.19 |
Net Worth | 13.71 | 11.69 | 1.07 | 0.33 |
Reserves and Surplus | 3.25 | 6.79 | ||
Amount in ₹ Crore |
About Medistep Healthcare IPO
Incorporated in June 2023, Medistep Healthcare Limited is a pharmaceutical company producing sanitary pads, energy powder, and various pharmaceutical, nutraceutical, intimate, and surgical products. They are committed to quality and seek to expand their product line as a public, non-government company.
The product includes the followings:-
- Sanitary Pads: Medistep produces high-quality sanitary pads, addressing essential feminine hygiene needs.
- Energy Powder: The company manufactures energy supplements designed to revitalize and invigorate consumers.
- Pharmaceutical Products: Medistep engages in the trading of various pharmaceutical items, ensuring accessibility to essential medications.
- Nutraceutical Products: They offer products that blend nutrition and pharmaceuticals, promoting overall health and wellness.
- Intimate Care and Hygiene Products: The company provides personal hygiene and intimate care products.
- Surgical Products: Medistep supplies surgical items and supports medical professionals with necessary tools and equipment.
As of December 30, 2024, Medistep reported annualized revenues of ₹45.00 crore and a Profit After Tax (PAT) of ₹4.08 crore.
As of December 28, 2024, the company has nine employees on payroll. Labour needs depend on daily-paid labourers, and none are on contract.
Strength Of Medistep Healthcare IPO
1. Experienced Promoters and Senior Management with extensive domain knowledge.
2. Quality assurance and control.
3. Market Potential.
4. Investment in latest technology and maintain our edge in the market.
Risk Of Medistep Healthcare IPO
1. The company provide its goods majorly in Gujarat, any adverse changes in the conditions affecting these regions can adversely affect its business, financial condition and results of operations.
2. The company manufacturing facility are subject to operational risks. Any slowdown or shutdown in its manufacturing operations could adversely affect the company business, financial condition and results of operations.
3. The company relies on domestic third-party suppliers for the supply of raw materials and any delay, interruption or reduction in such supply could adversely affect its business, results of operations, financial condition and cash flows.
4. The company is subject to extensive government regulations and if its fail to obtain, maintain or renew the company statutory and regulatory licenses, permits and approvals required to operate its business, the company business, financial condition, results of operations and cash flows may be adversely affected.
5. The Company is dependent on few numbers of customers for sales. The loss of any of this large customer may affect its revenues and profitability.
6. Any increase in the cost of its raw material or other purchases or a shortfall in the supply of the company raw materials, may adversely affect the pricing and supply of its products and have an adverse effect on the company business, results of operations and financial condition.
7. If the company is unable to patent new processes, obtain trademarks for its products, or protect such proprietary information, the company business may be adversely affected.
8. The company inability to accurately forecast demand for its products and manage the company inventory may have an adverse effect on its business, financial condition, results of operations and cash flows.
9. The company has had negative cash flows from investing activities during the Financial Year 2024. Negative cash flows over extended periods, or significant negative cash flows in the short term, could affect its ability to operate the company business and implement its growth plans.
10. The company requires working capital for its smooth day-to-day operations of business and any discontinuance or its inability to acquire adequate working capital timely and on favourable terms may have an adverse effect on its operations, profitability and growth prospects.
Objectives Medistep Healthcare IPO
1. Funding of capital expenditure towards purchase of plant and machineries for expansion at the existing manufacturing facility
2. Working Capital requirements
3. General Corporate Purpose
Company Contact Details
Medistep Healthcare Ltd.
05, S. No-245/B, Plot-19, T.P.S. 56,
Free Way Trade Center, Nr.A-One Hotel N.H.-8
Narol Gam, Narol Daskroi,
Ahmedabad, Gujarat, 382405
Phone: +91 87808 46963
Email: Info@medistephc.com
Website: https://www.medistephc.com/
Registrar Contact Details
Lead Mangers
Lead Manager Reports
Market Maker
Market Maker Reports
Read more about Shringar House of Mangalsutra IPO
- Medistep Healthcare Limited IPO Detail
- Medistep Healthcare Limited IPO Subscription Detail
- Medistep Healthcare Limited IPO GMP Detail
- Checked Live Medistep Healthcare Limited IPO Allotment Status
- Medistep Healthcare Limited IPO Basis Of Allotment
- Medistep Healthcare Limited IPO Price Calculator
- Medistep Healthcare Limited IPO Stock Price